Filing Details

Accession Number:
0001209191-17-054196
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-27 21:40:34
Reporting Period:
2017-09-25
Accepted Time:
2017-09-27 21:40:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611024 D David Chang C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Evp, R&D, Chief Medical Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-25 15,000 $0.00 65,350 No 4 A Direct
Common Stock Disposition 2017-09-25 7,927 $179.66 57,423 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Includes 185 shares acquired under the 2014 Employee Stock Purchase Plan on August 18, 2017.
  2. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.